TRPM7 channels mediate the functional changes in cardiac fibroblasts induced by angiotensin II

Sha Li, Mingjiang Li, Xin Yi, Furong Guo, Yanli Zhou, Suqin Chen, Xian WuInternational Journal of Molecular Medicine 2017 · DOI

Abstract

Transient receptor potential melastatin 7 (TRPM7), a bifunctional channel protein owning both cation permeability and kinase activity, plays an important role in the pathophysiological process of many cell types, such as vascular smooth muscle cells, human glioma cells and mouse cortical astrocytes. However, whether TRPM7 channels play a key role in the functional change of cardiac fibroblasts (CFs) induced by angiotensin II (Ang II) remains unknown. Using Cell Counting Kit-8 (CCK-8) assay, immunofluorescence assay, western blot analysis, RT-qPCR, RNA interference (RNAi) and whole-cell patch-clamp techniques, the present study aimed to explore the role of TRPM7 channels in the proliferation, differentiation and collagen synthesis of CFs induced by Ang II. Our data showed that Ang II time-dependently increased TRPM7 expression and TRPM7 currents in the CFs. Downregulation of TRPM7 attenuated the TRPM7 current density, and inhibited the proliferation, differentiation and collagen synthesis of CFs induced by Ang II. Our results identified the TRPM7 channel as a pivotal member associated with the functional change of CFs induced by Ang II, and suggest that the TRPM7 channel may represent a promising therapeutic strategy for the treatment of fibrosis-related cardiac diseases.

Introduction

Cardiac fibrosis—the excessive deposition of extracellular matrix (ECM) proteins like collagen—is a hallmark of many heart diseases. It stiffens the heart muscle, impairs pumping efficiency, and disrupts electrical signals, leading to arrhythmias. The primary "engine" of this process is the cardiac fibroblast (CF). When triggered by pathological stimuli like Angiotensin II (Ang II), these cells transform into hyper-active myofibroblasts. While calcium ($Ca^{2+}$) signaling is known to be essential for this transformation, the specific "gatekeeper" channel responsible for $Ca^{2+}$ influx in these cells has remained a subject of intense study. This research investigates whether TRPM7 (Transient Receptor Potential Melastatin 7), a unique protein that acts as both an ion channel and a kinase, is the critical link in Ang II-induced fibrosis.

Methods

The researchers used primary cardiac fibroblasts isolated from neonatal Sprague-Dawley rats. To explore the role of TRPM7, they employed a multi-disciplinary approach:

  • Gene Silencing: Adenovirus-mediated RNA interference (siRNA) was used to "knock down" TRPM7 expression to observe the effects of its absence.
  • Electrophysiology: Whole-cell patch-clamp techniques measured TRPM7 ion currents across the cell membrane.
  • Molecular Assays: RT-qPCR and Western blotting measured mRNA and protein levels of TRPM7 and fibrotic markers (Collagen I, Collagen III, and $\alpha$-SMA).
  • Functional Assays: The CCK-8 assay measured cell proliferation, while immunofluorescence visualized cell differentiation into myofibroblasts.

Results

Ang II Upregulates TRPM7 Expression

The study found that Ang II (1 $\mu$M) significantly increases the expression of TRPM7 protein and mRNA in a time-dependent manner, with levels peaking at 24 hours.

Figure 1: Ang II increases TRPM7 protein expression in CFs over time.

Silencing TRPM7 Attenuates Fibrotic Responses

To confirm the functional role of TRPM7, the researchers utilized siRNA to silence the gene. The most effective sequence (siRNA2) reduced TRPM7 protein expression by 84.5%.

Figure 2: Efficiency of TRPM7 silencing using siRNA at protein and mRNA levels.

Key findings from the knockdown experiments include:

  • Current Density: Ang II increased inward current density by ~2-fold and outward current density by ~3-fold. TRPM7-siRNA almost entirely abolished this increase.
  • Differentiation and Proliferation: Silencing TRPM7 prevented the expression of $\alpha$-smooth muscle actin ($\alpha$-SMA), a marker of myofibroblast differentiation, and markedly reduced proliferation markers Ki-67 and PCNA.
  • Collagen Inhibition: TRPM7 knockdown reduced Ang II-induced Collagen I and III synthesis by 85.0% and 71.6%, respectively.

Discussion and Future Directions

This study clearly establishes TRPM7 as a pivotal player in the functional changes of cardiac fibroblasts induced by Ang II. By regulating the transition to myofibroblasts and the subsequent synthesis of collagen, TRPM7 represents a promising therapeutic target for treating fibrosis-related heart diseases.

Future work is needed to map the exact downstream signaling pathways connecting TRPM7-mediated $Ca^{2+}$ influx to gene expression and to explore the role of its unique alpha-kinase domain. Furthermore, while these in vitro results are compelling, in vivo validation in animal models is a necessary next step toward clinical application.

Summary updated

Abstract

Transient receptor potential melastatin 7 (TRPM7), a bifunctional channel protein owning both cation permeability and kinase activity, plays an important role in the pathophysiological process of many cell types, such as vascular smooth muscle cells, human glioma cells and mouse cortical astrocytes. However, whether TRPM7 channels play a key role in the functional change of cardiac fibroblasts (CFs) induced by angiotensin II (Ang II) remains unknown. Using Cell Counting Kit-8 (CCK-8) assay, immunofluorescence assay, western blot analysis, RT-qPCR, RNA interference (RNAi) and whole-cell patch-clamp techniques, the present study aimed to explore the role of TRPM7 channels in the proliferation, differentiation and collagen synthesis of CFs induced by Ang II. Our data showed that Ang II time-dependently increased TRPM7 expression and TRPM7 currents in the CFs. Downregulation of TRPM7 attenuated the TRPM7 current density, and inhibited the proliferation, differentiation and collagen synthesis of CFs induced by Ang II. Our results identified the TRPM7 channel as a pivotal member associated with the functional change of CFs induced by Ang II, and suggest that the TRPM7 channel may represent a promising therapeutic strategy for the treatment of fibrosis-related cardiac diseases.
BibTeX
@article{li2017trpm,
  author = {Sha Li and Mingjiang Li and Xin Yi and Furong Guo and Yanli Zhou and Suqin Chen and Xian Wu},
  title = {{TRPM7 channels mediate the functional changes in cardiac fibroblasts induced by angiotensin II}},
  journal = {International Journal of Molecular Medicine},
  year = {2017},
  doi = {10.3892/ijmm.2017.2943},
}
Figure